MCL: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
YazanDaaboul (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
What are you looking for? | What are you looking for? | ||
*[[Medial collateral ligament]], one of | *[[Mantle cell lymphoma]], a subtype of [[B-cell lymphoma]] | ||
*[[ | *[[Mast cell leukemia]], an aggressive subtype of [[acute myeloid leukemia]] | ||
*[[Medial collateral ligament]], one of many ligaments of the knee | |||
*[[Midclavicular line]] | |||
*[[Mucocutaneous leishmaniasis]], an infection caused by ''[[Leishmania]]'' spp. parasites | |||
*[[Multiple cutaneous leiomyoma]], a subtype of [[leiomyoma]] (smooth muscle tumor) | |||
*[[Bcl-2|Myeloid cell leukemia sequence 1 (MCL-1) gene]], a member of the BCL-2 family, that encodes the "induced myeloid leukemia cell differentiation" (mcl-1) protein that is targeted by pharmacologic agents such as [[Omacetaxine]], Mepesuccinate, and [[Seliciclib]] | |||
Revision as of 16:55, 4 September 2015
What are you looking for?
- Mantle cell lymphoma, a subtype of B-cell lymphoma
- Mast cell leukemia, an aggressive subtype of acute myeloid leukemia
- Medial collateral ligament, one of many ligaments of the knee
- Midclavicular line
- Mucocutaneous leishmaniasis, an infection caused by Leishmania spp. parasites
- Multiple cutaneous leiomyoma, a subtype of leiomyoma (smooth muscle tumor)
- Myeloid cell leukemia sequence 1 (MCL-1) gene, a member of the BCL-2 family, that encodes the "induced myeloid leukemia cell differentiation" (mcl-1) protein that is targeted by pharmacologic agents such as Omacetaxine, Mepesuccinate, and Seliciclib